| Emily Yorges, DPT | |
|
1301 E M St, Torrington, WY 82240-3521 | |
| (307) 532-5355 | |
| Not Available |
| Full Name | Emily Yorges |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1301 E M St, Torrington, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750087557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2239 (Wyoming) | Primary |
| Provider Name | North Platte Physical Therapy Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093914111 PECOS PAC ID: 8921080565 Enrollment ID: O20040607000307 |
News Archive
A study on the pain at the base of the thumb conducted in the University of Malaga has evidenced that a continuous use of the mobile phone, especially among young people, goes hand in hand with new pathologies of this finger.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.
The moment a bacterial pathogen makes contact with its host, its goal is simple: to infect.
A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
› Verified 2 days ago
| Provider Name | Big Country Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366493264 PECOS PAC ID: 0648253666 Enrollment ID: O20040610001233 |
News Archive
A study on the pain at the base of the thumb conducted in the University of Malaga has evidenced that a continuous use of the mobile phone, especially among young people, goes hand in hand with new pathologies of this finger.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.
The moment a bacterial pathogen makes contact with its host, its goal is simple: to infect.
A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
› Verified 2 days ago
| Provider Name | Bear Lodge Rehabilitation Services, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1558690099 PECOS PAC ID: 7911041199 Enrollment ID: O20100225000900 |
News Archive
A study on the pain at the base of the thumb conducted in the University of Malaga has evidenced that a continuous use of the mobile phone, especially among young people, goes hand in hand with new pathologies of this finger.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.
The moment a bacterial pathogen makes contact with its host, its goal is simple: to infect.
A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Yorges, DPT Po Box 1790, Douglas, WY 82633-1790 Ph: (307) 358-9464 | Emily Yorges, DPT 1301 E M St, Torrington, WY 82240-3521 Ph: (307) 532-5355 |
News Archive
A study on the pain at the base of the thumb conducted in the University of Malaga has evidenced that a continuous use of the mobile phone, especially among young people, goes hand in hand with new pathologies of this finger.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.
The moment a bacterial pathogen makes contact with its host, its goal is simple: to infect.
A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.
GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.
› Verified 2 days ago
Dr Taryn Kilty Physical Therapy & Wellness Physical Therapist Medicare: Medicare Enrolled Practice Location: 1913 Main St, Torrington, WY 82240 Phone: 307-630-0740 Fax: 307-222-6208 | |
Jay T Pierce, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1301 E M St, Torrington, WY 82240 Phone: 307-532-5355 Fax: 307-532-5455 | |
Kimberly Janae Hansen, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 680 E Valley Rd, Torrington, WY 82240 Phone: 307-532-5355 | |
Joe W Fuller, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1301 E M St, Ste B, Torrington, WY 82240 Phone: 307-532-4694 Fax: 307-532-7241 | |
Brittney Lynn Walters, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1301 E M St, Torrington, WY 82240 Phone: 307-532-5355 | |
Amanda Hicks, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1301 E M St, Torrington, WY 82240 Phone: 307-532-5355 Fax: 307-532-5455 | |
North Platte Physical Therapy Services, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 680 E Valley Rd, Torrington, WY 82240 Phone: 307-532-5355 |